Mechanisms of COX-2 inhibitors a possible link to CV events?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1056卷 / 1期
关键词：
Blood Flow; Medium Release; Organ Transplant; Prostacyclin; Vessel Diameter;
D O I：
10.2165/00128415-200510560-00009
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [31] COX-2 inhibitors - Reply
    Hawkey, CJ
    LANCET, 1999, 353 (9162): : 1440 - 1440
  • [32] Selective COX-2 inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1997, 2 (03) : 122 - 122
  • [33] Nomenclature for COX-2 inhibitors
    Vane, JR
    Warner, TD
    LANCET, 2000, 356 (9239): : 1373 - 1374
  • [34] COX-2 inhibitors - Preface
    Dannhardt, G
    CURRENT MEDICINAL CHEMISTRY, 2000, 7 (11)
  • [35] Defining COX-2 inhibitors
    Lipsky, PE
    JOURNAL OF RHEUMATOLOGY, 2000, 27 : 13 - 16
  • [36] COX-2 inhibitors and ligaments
    Mitka, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24): : 3071 - 3071
  • [37] COX-2 inhibitors and the kidney
    Perazella, MA
    HOSPITAL PRACTICE, 2001, 36 (03): : 43 - +
  • [38] COX-2 inhibitors - Preface
    Brooks, PM
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (17) : U2 - U4
  • [39] COX-2 inhibitors and hypertension
    Weder, Alan B.
    Zhang, J.
    Ding, E. L.
    Song, Y.
    CURRENT HYPERTENSION REPORTS, 2007, 9 (01) : 3 - 4
  • [40] COX-1 and COX-2 inhibitors
    Hawkey, CJ
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (05) : 801 - 820
12345